Adma Biologics Inc (ADMA)

R&D Expense Growth

131.57%

Quarterly · Period ending:

ADMA logo

ADMA R&D Expense Growth

Latest reported131.57%
ADMA Quarterly R&D Growth (QoQ) (0.00% → 131.57%)
High-resolution chart · PNG

ADMA r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Adma Biologics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
131.5749%
88.7355%
-9.9476%
48.2056%
24.8184%
111.2532%
-5.0971%
-26.4286%
24.4444%
1.0133%
-25.254%
-57.5196%
64.0936%
-20.4148%
3.107%
19.2997%
39.9408%
-14.3867%
-5.3947%
-33.5077%
17.3358%
-2.5472%
-40.6773%
3.1375%
8.3521%
228.886%
-5.4092%
-4.9483%
-40.6197%
700.7694%
-111.0018%
-10.5201%
14.8547%
-31.253%
2.7735%
33.5437%
13.891%
104.4532%
-65.2187%
-50.6671%
67.6712%
1.5477%
-5.432%
40.2146%
7.4327%
-26.9829%
29.4545%
-16.8719%
-58.8055%
46.4896%
109.8065%
-59.3992%
136.4669%
15.7449%
-34.6634%
986.1328%
118.3745%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.